In vivo assessment of aortic aneurysm wall integrity using elastin-specific molecular magnetic resonance imaging.
Botnar RM, Wiethoff AJ, Ebersberger U, Lacerda S, Blume U, Warley A, Jansen CH, Onthank DC, Cesati RR, Razavi R, Marber MS, Hamm B, Schaeffter T, Robinson SP, Makowski MR.
Botnar RM, et al.
Circ Cardiovasc Imaging. 2014 Jul;7(4):679-89. doi: 10.1161/CIRCIMAGING.113.001131. Epub 2014 May 28.
Circ Cardiovasc Imaging. 2014.
PMID: 24871347
An elastin-specific magnetic resonance molecular imaging agent (ESMA) was administered after 1, 2, 3, and 4 weeks of angiotensin-II infusion to assess elastin composition of the aorta (n=8 per group). The high signal provided by ESMA allowed for imaging with high sp …
An elastin-specific magnetic resonance molecular imaging agent (ESMA) was administered after 1, 2, 3, and 4 weeks of angiotensin-II i …